Publication:
Heteroresistance to Piperacillin-Tazobactam in Clinical Isolates of Escherichia coli Sequence Type 131

Simple item page
dc.contributor.authorRodriguez-Villodres, Angel
dc.contributor.authorOrtiz de la Rosa, Jose Manuel
dc.contributor.authorAlvarez-Marin, Rocio
dc.contributor.authorPachon, Jeronimo
dc.contributor.authorAznar, Javier
dc.contributor.authorAntonio Lepe, Jose
dc.contributor.authorSmani, Younes
dc.contributor.authoraffiliation[Rodriguez-Villodres, Angel] Univ Seville, Clin Unit Infect Dis Microbiol & Prevent Med, IBiS, Univ Hosp Virgen Rocio,CSIC, Seville, Spain
dc.contributor.authoraffiliation[Ortiz de la Rosa, Jose Manuel] Univ Seville, Clin Unit Infect Dis Microbiol & Prevent Med, IBiS, Univ Hosp Virgen Rocio,CSIC, Seville, Spain
dc.contributor.authoraffiliation[Alvarez-Marin, Rocio] Univ Seville, Clin Unit Infect Dis Microbiol & Prevent Med, IBiS, Univ Hosp Virgen Rocio,CSIC, Seville, Spain
dc.contributor.authoraffiliation[Pachon, Jeronimo] Univ Seville, Clin Unit Infect Dis Microbiol & Prevent Med, IBiS, Univ Hosp Virgen Rocio,CSIC, Seville, Spain
dc.contributor.authoraffiliation[Aznar, Javier] Univ Seville, Clin Unit Infect Dis Microbiol & Prevent Med, IBiS, Univ Hosp Virgen Rocio,CSIC, Seville, Spain
dc.contributor.authoraffiliation[Antonio Lepe, Jose] Univ Seville, Clin Unit Infect Dis Microbiol & Prevent Med, IBiS, Univ Hosp Virgen Rocio,CSIC, Seville, Spain
dc.contributor.authoraffiliation[Smani, Younes] Univ Seville, Clin Unit Infect Dis Microbiol & Prevent Med, IBiS, Univ Hosp Virgen Rocio,CSIC, Seville, Spain
dc.contributor.authoraffiliation[Pachon, Jeronimo] Univ Seville, Dept Med, Seville, Spain
dc.contributor.authoraffiliation[Aznar, Javier] Univ Seville, Dept Microbiol, Seville, Spain
dc.contributor.funderMiguel Servet Tipo I Project grant, Instituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia, Industria y Competitividad
dc.contributor.funderPlan Nacional de I + D + i
dc.contributor.funderInstituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia, Industria y Competitividad, Spanish Network for Research in Infectious Diseases
dc.contributor.funderEuropean Development Regional Fund "A Way to Achieve Europe"
dc.contributor.funderSubprograma Miguel Servet Tipo I, Instituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia y Competitividad, Spain
dc.date.accessioned2023-02-12T02:21:38Z
dc.date.available2023-02-12T02:21:38Z
dc.date.issued2018-01-01
dc.identifier.doi10.1128/AAC.01923-17
dc.identifier.essn1098-6596
dc.identifier.issn0066-4804
dc.identifier.unpaywallURLhttps://europepmc.org/articles/pmc5740306?pdf=render
dc.identifier.urihttp://hdl.handle.net/10668/19006
dc.identifier.wosID418565300064
dc.issue.number1
dc.journal.titleAntimicrobial agents and chemotherapy
dc.journal.titleabbreviationAntimicrob. agents chemother.
dc.language.isoen
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationHospital Universitario Virgen del Rocío
dc.publisherAmer soc microbiology
dc.rights.accessRightsopen access
dc.subjectEscherichia coli
dc.subjectST131
dc.subjectheteroresistance
dc.subjectpiperacillin-tazobactam
dc.titleHeteroresistance to Piperacillin-Tazobactam in Clinical Isolates of Escherichia coli Sequence Type 131
dc.typeletter
dc.type.hasVersionVoR
dc.volume.number62
dc.wostypeLetter
dspace.entity.typePublication

Files

Collections

Instituto de Investigación Biomédica de Sevilla (IBIS)
SAS - Hospital Universitario Virgen del Rocío

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía